Frontage Holdings Corporation
HKEX:1521.HK
Overview | Financials
Company Name | Frontage Holdings Corporation |
Symbol | 1521.HK |
Currency | HKD |
Price | 0.94 |
Market Cap | 1,913,576,800 |
Dividend Yield | 0% |
52-week-range | 0.47 - 2.33 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Song Li Ph.D. |
Website | https://www.frontagelab.com |
An error occurred while fetching data.
About Frontage Holdings Corporation
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD